BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

42 related articles for article (PubMed ID: 35116692)

  • 1. Clinical Trials with Combination of Cytokine-Induced Killer Cells and Dendritic Cells for Cancer Therapy.
    Garofano F; Gonzalez-Carmona MA; Skowasch D; Schmidt-Wolf R; Abramian A; Hauser S; Strassburg CP; Schmidt-Wolf IGH
    Int J Mol Sci; 2019 Sep; 20(17):. PubMed ID: 31484350
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of interleukin-2 concentration and administration method on proliferation and function of cytokine-induced killer cells.
    Liu Y; Li J; Zhao L; Zhu J; Liu S; Wang H; Zhang Y
    Transl Cancer Res; 2021 Sep; 10(9):3930-3938. PubMed ID: 35116692
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Augmented CD3(+)CD8(+) and CD3(+)CD56(-) cells in cytokine-induced killer cells cultured with engineered cells for costimulatory enhancement from heavily pretreated patients with solid tumor.
    Wang L; Yi Y; Yin D; Zhou Z; Fan J; Ye W; Zhao W
    Cytotherapy; 2016 Apr; 18(4):581-9. PubMed ID: 26971686
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synergistic effect of CH-296 and interferon gamma on cytokine-induced killer cells expansion for patients with advanced-stage malignant solid tumors.
    Yu J; Ren X; Li H; Cao S; Han Y; Enoki T; Kato I; Cao C; Hao X
    Cancer Biother Radiopharm; 2011 Aug; 26(4):485-94. PubMed ID: 21797674
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of autologous dendritic cells on cytokine-induced killer cell proliferation, cell phenotype and antitumor activity
    Cao J; Chen C; Wang Y; Chen X; Chen Z; Luo X
    Oncol Lett; 2016 Sep; 12(3):2033-2037. PubMed ID: 27602134
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of cytotoxic potency between freshly cultured and freshly thawed cytokine-induced killer cells from human umbilical cord blood.
    Ngo HT; Dang VT; Nguyen NH; Bui AN; Van Pham P
    Cell Tissue Bank; 2023 Mar; 24(1):139-152. PubMed ID: 35792988
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Experimental study on the treatment of intracerebral glioma xenograft with human cytokine-induced killer cells.
    Wang P; Yu JP; Gao SY; An XM; Ren XB; Wang XG; Li WL
    Cell Immunol; 2008; 253(1-2):59-65. PubMed ID: 18522858
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CIK cell cytotoxicity is a predictive biomarker for CIK cell immunotherapy in postoperative patients with hepatocellular carcinoma.
    Pan QZ; Liu Q; Zhou YQ; Zhao JJ; Wang QJ; Li YQ; Tang Y; Gu JM; He J; Chen SP; Weng DS; Xia JC
    Cancer Immunol Immunother; 2020 May; 69(5):825-834. PubMed ID: 32060687
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interleukin-2 as immunotherapeutic in the autoimmune diseases.
    Orozco Valencia A; Camargo Knirsch M; Suavinho Ferro E; Antonio Stephano M
    Int Immunopharmacol; 2020 Apr; 81():106296. PubMed ID: 32058934
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical effect and safety of dendritic cell-cytokine-induced killer cell immunotherapy for pancreatic cancer: a systematic review and meta-analysis.
    Liu YL; Yang LX; Zhang F; Tang BS; Zhao LT; Zhu JR; Jin QY; Wang RX; Li YM
    Cytotherapy; 2019 Oct; 21(10):1064-1080. PubMed ID: 31462394
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improving Clinical Manufacturing of IL-15 Activated Cytokine-Induced Killer (CIK) Cells.
    Bremm M; Pfeffermann LM; Cappel C; Katzki V; Erben S; Betz S; Quaiser A; Merker M; Bonig H; Schmidt M; Klingebiel T; Bader P; Huenecke S; Rettinger E
    Front Immunol; 2019; 10():1218. PubMed ID: 31214182
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined Treatment with Autologous CIK Cells, Radiotherapy and Chemotherapy in Advanced Cervical Cancer.
    Li N; Tian YW; Xu Y; Meng DD; Gao L; Shen WJ; Liu ZL; Xu ZQ
    Pathol Oncol Res; 2019 Apr; 25(2):691-696. PubMed ID: 30511107
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cancer incidence and mortality in China in 2013: an analysis based on urbanization level.
    Chen W; Zheng R; Zhang S; Zeng H; Zuo T; Xia C; Yang Z; He J
    Chin J Cancer Res; 2017 Feb; 29(1):1-10. PubMed ID: 28373748
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The future of cancer treatment: immunomodulation, CARs and combination immunotherapy.
    Khalil DN; Smith EL; Brentjens RJ; Wolchok JD
    Nat Rev Clin Oncol; 2016 May; 13(5):273-90. PubMed ID: 26977780
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.